Duration of storage of autologous hematopoietic stem cell products for children and adolescents with malignant diseases;Dauer der einlagerung autologer blutstammzellprodukte von kindern und jugendlichen mit malignen erkrankungen

Klinische Padiatrie

Volumn 217, Issue 6, 2005, Pages 371-373

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CRYOPRESERVATION; EWING SARCOMA; HEMATOPOIETIC STEM CELL; HEPATOBLASTOMA; HUMAN; MEDULLOBLASTOMA; NEPHROBLASTOMA; NEUROBLASTOMA; OSTEOSARCOMA; RETINOBLASTOMA; STORAGE;

BLOOD TRANSFUSION, AUTOLOGOUS; BONE MARROW TRANSPLANTATION; CHILD; CRYOPRESERVATION; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NATIONAL HEALTH PROGRAMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; SPECIMEN HANDLING; TREATMENT OUTCOME;

EID: 28544433367     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-872545     Document Type: Article

References (17)

1. Attarian H, Feng Z, Buckner CD, MacLeod B, Rowley SD. Long-term cryopreservation of bone marrow for autologous transplantation. Bone Marrow Transplant 1996; 17: 425-430
2. Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling F, Schrappe M, Simon T, Hero B. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncology 2005; 6: 649-658
3. Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA 2003; 100: 645-650
4. Burdach S, Meyer-Bahlburg A, Laws HJ, Haase R, Kaik B van, Metzner B, Wawer A, Finke R, Göbel U, Haerting J, Pape H, Gadner H, Dunst J, Jürgens H. High-Dose Therapy for Patients with Primary Multifocal and Early Relapsed Ewing's Tumors: Results of Two Consecutive Regimens Assessing the Role of Total-Body Irradiation. J Clin Oncol 2003; 16: 3072-3078
5. Dallorso S, Dini G, Ladenstein R, Cama A, Milanaccio C, Barra S, Cappelli B, Garré GL, on behalf of EBMT-PDWP. Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours. Bone Marrow Transplantation 2005; 35: S31-S34
6. De Giorgi U, Rosti G, Slavin S, Yaniv I, Harousseau JL, Ladenstein R, Demirer T, Dini G. Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours. Br J Cancer 2005; 93: 412-417
7. Donnenberg AD, Koch EK, Griffin DL, Stanczak HM, Kiss JE, Carlos TM, Buchbarker DM, Yeager AM. Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy 2002; 4: 157-163
8. Franzius C, Bielack S, Flege S, Eckardt J, Sciuk J, Jurgens H, Schober O. High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcoma. Nuklearmedizin 2001; 40: 215-220
9. Häberle B, Bode U, Schweinitz D von. Differenzierte Therapieansätze für Hochrisiko- und Standardrisiko-Hepatoblastome. Klin Pädiatr 2003;215:59-165
10. Jahresbericht 2001 des Pädiatrischen Registers für Stammzell-Transplantationen (PRST).
11. Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws HJ, Koscielniak E, Hero B, Selle B, Niemeyer C, Finckenstein FG, Schuolz A, Waver A, Zintl F, Graf N. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant 2002; 30: 893-898
12. Kremens B, Wieland R, Reinhard H, Neubert D, Beck JD, Klingebiel T, Bornfeld N, Havers W. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant 2003; 31: 281-284
13. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341: 1165-1173
14. Mugishima H, Harada K, Chin M, Suzuki T, Takagi K, Hayakawa S, Sato K, Klein JP, Gale RP. Effects of long-term cryopreservation on hematopoietic progenitor cells in umbilical cord blood. Bone Marrow Transplant 1999; 23: 395-396
15. Spurr EE, Wiggins NE, Marsden KA, Lowenthal RM, Ragg SJ. Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage. Cryobiology 2002; 44: 210-217
16. Tepmongkol S, Heyman S. 131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current status. Med Pediatr Oncol 1999; 32: 427-431
17. Wessalowski R, Schneider DT, Mils O, Hannen M, Calaminus G, Engelbrecht V, Pape H, Willers R, Engert J, Harms D, Göbel U. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors. Klin Pädiatr 2003; 215: 289-360